HBK Sorce Advisory’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
HL
HBK Sorce Advisory's GMAB Position: Q1 2024 in Review
HBK Sorce Advisory sold out of Genmab (GMAB) in Q1 2024, closing a stake of 7,073 shares — an estimated $225K sold.
HBK Sorce Advisory first reported a position in GMAB in Q3 2019 and held it in 18 quarters. The position peaked at $779K in Q4 2022. 227 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.
- HBK Sorce Advisory reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
- HBK Sorce Advisory sold 7,073 Genmab shares in Q1 2024, an estimated $225K.
- HBK Sorce Advisory first reported a position in Genmab in Q3 2019 and held it in 18 quarters.
- HBK Sorce Advisory's Genmab position peaked at $779K in Q4 2022.
- 227 funds tracked by Wall St. Rank held Genmab as of Q1 2024.
Based on HBK Sorce Advisory's 13F filing for Q1 2024, filed 9 May 2024.